Evofem Biosciences, Inc. Gains 92.31%
Tue, Mar 21, 2023 at 07:07 PM
Evofem Biosciences, Inc. (EVFM:NASDAQ) jumped higher at $0.03, a gain of 92.3%. On Tue, Mar 21, 2023, EVFM:NASDAQ touched a New 2-Week Intraday High of $0.03. The stock appeared on our News Catalysts scanner on Mon, Feb 27, 2023 at 08:39 AM in the 'BIOTECH' category. From Tue, Mar 07, 2023, the stock recorded 10.00% Up Days and 18.18% Green Days
About Evofem Biosciences, Inc. (EVFM:NASDAQ)
Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Top 10 Gainers:
- U.S. Xpress Enterprises, Inc. (USX:NYSE), 298.67%
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 92.31%
- Impac Mortgage Holdings, Inc. (IMH:NYSEMKT), 89.81%
- Quince Therapeutics Inc Com (QNCX:NASDAQ), 71.1%
- Pear Therapeutics Inc. (PEAR:NASDAQ), 59.88%
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 39.48%
- ImmunityBio Inc. (IBRX:NASDAQ), 36.3%
- Paratek Pharmaceuticals, Inc. (PRTK:NASDAQ), 35.77%
- SCYNEXIS, Inc. (SCYX:NASDAQ), 35.65%
- Envirotech Vehicles Inc. (EVTV:NASDAQ), 33.33%